NIH-funded research NIH-funded research

Mapping the genetic effects of Down syndrome on organ development

Official title: Trisomy 21 Model Atlas

Funded at University of Colorado Denver · NIH-10930970 · Data updated 2026-11-12

This study is looking at how Down syndrome affects the way genes work in different parts of the body, using mice and special human cells, to help us understand more about the condition and find better ways to support people with it, including those at risk for Alzheimer's disease.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startSeptember 19, 2023
Project endAugust 31, 2027
Funding year2024
Award (this year)$768,701
NIH project number5R24OD035579-02
Project IDNIH-10930970 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with Down syndrome, particularly those experiencing co-occurring conditions such as Alzheimer's disease.

Less likely to help

Patients without Down syndrome or those who do not have related health conditions may not benefit from this research.

What this research studies

This research investigates how trisomy 21, the genetic cause of Down syndrome, affects gene expression in various tissues and organs. By using mouse models and human induced pluripotent stem cells, the study aims to create a comprehensive atlas that details how these genetic changes influence organ development and contribute to associated health conditions like Alzheimer's disease. Patients can benefit from insights gained about the underlying mechanisms of their condition, which may lead to improved treatments and care strategies.

Why it matters

Potential benefit: If successful, this research could lead to better understanding and management of health issues associated with Down syndrome.

How similar studies have gone: Previous research using similar models has shown promise in understanding genetic conditions, indicating potential for success in this novel approach.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Galbraith, Matthew D — University of Colorado Denver
  • Study coordinator: Galbraith, Matthew D

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.